| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.08 |